Zoology · 2022
NEET 2022 · 17 July · Code R6 · Q174
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because :
Official answer
From NTA’s final answer key for this paper.
(1)
Genetically engineered lymphocytes are not immortal cells.
More from Biotechnology and its Applications
- Why can't insulin be given orally to diabetic patients?2025
- Which of the following genetically engineered organisms was used by Eli Lilly to prepare human insulin?2025
- Silencing of specific mRNA is possible via RNAi because of -2025
- The human protein named α-1 -antitrypsin, obtained from transgenic animals, is used for the treatment of ____.2026
- Match List I with List II: List I A. α-1 antitrypsin B. Cry IAb C. Cry IAc D. Enzyme replacement therapy List…2024
NEET (UG) 2022 Zoology question, with the answer from NTA’s final answer key. Where our answers come from.